Janney Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.32M | Sell |
52,880
-12,843
| -20% | -$324K | 0.08% | 142 |
|
|
2025
Q3 | $1.68M | Buy |
+65,723
| New | +$1.62M | 0.1% | 129 |
|
|
2025
Q1 | – | Sell |
-395,819
| Closed | -$10.5M | – | 248 |
|
|
2024
Q4 | $10.5M | Sell |
395,819
-54,845
| -12% | -$1.49M | 0.69% | 61 |
|
|
2024
Q3 | $13M | Sell |
450,664
-946
| -0.2% | -$27.6K | 0.88% | 44 |
|
|
2024
Q2 | $12.6M | Sell |
451,610
-24,712
| -5% | -$680K | 0.89% | 42 |
|
|
2024
Q1 | $13.2M | Buy |
476,322
+16,388
| +4% | +$455K | 0.88% | 42 |
|
|
2023
Q4 | $13.2M | Buy |
459,934
+44,969
| +11% | +$1.36M | 0.89% | 38 |
|
|
2023
Q3 | $13.8M | Buy |
414,965
+5,094
| +1% | +$180K | 1.06% | 29 |
|
|
2023
Q2 | $15M | Buy |
409,871
+4,594
| +1% | +$179K | 1.04% | 29 |
|
|
2023
Q1 | $16.5M | Buy |
405,277
+12,536
| +3% | +$541K | 1.24% | 22 |
|
|
2022
Q4 | $20.1M | Buy |
392,741
+10,624
| +3% | +$509K | 1.44% | 17 |
|
|
2022
Q3 | $16.7M | Buy |
382,117
+6,159
| +2% | +$299K | 1.36% | 19 |
|
|
2022
Q2 | $19.7M | Buy |
375,958
+298
| +0.1% | +$15.2K | 1.58% | 19 |
|
|
2022
Q1 | $19.4M | Buy |
375,660
+14,390
| +4% | +$747K | 1.38% | 21 |
|
|
2021
Q4 | $21.3M | Sell |
361,270
-3,918
| -1% | -$194K | 1.39% | 20 |
|
|
2021
Q3 | $15.7M | Sell |
365,188
-6,072
| -2% | -$269K | 1.05% | 29 |
|
|
2021
Q2 | $14.5M | Sell |
371,260
-2,575
| -0.7% | -$100K | 0.93% | 34 |
|
|
2021
Q1 | $13.5M | Sell |
373,835
-7,502
| -2% | -$266K | 0.9% | 38 |
|
|
2020
Q4 | $14M | Sell |
381,337
-41,751
| -10% | -$1.53M | 0.97% | 29 |
|
|
2020
Q3 | $14.7M | Sell |
423,088
-48,419
| -10% | -$1.7M | 1.01% | 26 |
|
|
2020
Q2 | $14.6M | Sell |
471,507
-19,220
| -4% | -$653K | 1.01% | 31 |
|
|
2020
Q1 | $15.2M | Sell |
490,727
-58,646
| -11% | -$2M | 1.16% | 24 |
|
|
2019
Q4 | $20.4M | Sell |
549,373
-34,134
| -6% | -$1.22M | 1.1% | 27 |
|
|
2019
Q3 | $19.9M | Sell |
583,507
-20,544
| -3% | -$747K | 1.11% | 29 |
|
|
2019
Q2 | $24.8M | Sell |
604,051
-19,901
| -3% | -$790K | 1.35% | 19 |
|
|
2019
Q1 | $25.1M | Sell |
623,952
-15,647
| -2% | -$627K | 1.31% | 22 |
|
|
2018
Q4 | $26.5M | Sell |
639,599
-12,324
| -2% | -$512K | 1.43% | 16 |
|
|
2018
Q3 | $27.3M | Sell |
651,923
-16,578
| -2% | -$638K | 1.18% | 21 |
|
|
2018
Q2 | $23M | Sell |
668,501
-6,394
| -0.9% | -$219K | 1.01% | 30 |
|
|
2018
Q1 | $22.7M | Sell |
674,895
-9,286
| -1% | -$319K | 0.99% | 30 |
|
|
2017
Q4 | $23.5M | Sell |
684,181
-7,801
| -1% | -$266K | 1% | 28 |
|
|
2017
Q3 | $23.4M | Buy |
691,982
+30,807
| +5% | +$990K | 1.01% | 27 |
|
|
2017
Q2 | $21.1M | Sell |
661,175
-12,845
| -2% | -$405K | 0.99% | 32 |
|
|
2017
Q1 | $21.9M | Sell |
674,020
-6,813
| -1% | -$215K | 1.01% | 28 |
|
|
2016
Q4 | $21M | Sell |
680,833
-50,251
| -7% | -$1.53M | 0.96% | 30 |
|
|
2016
Q3 | $23.5M | Buy |
731,084
+231,699
| +46% | +$7.75M | 1.06% | 34 |
|
|
2016
Q2 | $16.7M | Buy |
499,385
+3,954
| +0.8% | +$126K | 0.88% | 51 |
|
|
2016
Q1 | $13.9M | Buy |
495,431
+19,090
| +4% | +$545K | 0.75% | 59 |
|
|
2015
Q4 | $14.6M | Sell |
476,341
-10,513
| -2% | -$331K | 0.64% | 67 |
|
|
2015
Q3 | $14.5M | Buy |
486,854
+458,524
| +1,619% | +$14.7M | 0.66% | 71 |
|
|
2015
Q2 | $901K | Buy |
28,330
+2,559
| +10% | +$83.4K | 0.13% | 38 |
|
|
2015
Q1 | $851K | Buy |
25,771
+154
| +0.6% | +$4.9K | 0.03% | 155 |
|
|
2014
Q4 | $757K | Buy |
25,617
+3,711
| +17% | +$106K | 0.04% | 128 |
|
|
2014
Q3 | $615K | Sell |
21,906
-760
| -3% | -$21.3K | 0.04% | 136 |
|
|
2014
Q2 | $638K | Buy |
22,666
+5,050
| +29% | +$144K | 0.04% | 135 |
|
|
2014
Q1 | $537K | Sell |
17,616
-2,618
| -13% | -$78.1K | 0.04% | 136 |
|
|
2013
Q4 | $588K | Buy |
20,234
+754
| +4% | +$21.9K | 0.04% | 128 |
|
|
2013
Q3 | $531K | Buy |
19,480
+512
| +3% | +$13.9K | 0.04% | 165 |
|
|
2013
Q2 | $504K | Buy |
+18,968
| New | +$524K | 0.05% | 123 |
|
Other funds holding PFE
Janney Capital Management's PFE Position: Q4 2025 in Review
Janney Capital Management reduced its Pfizer (PFE) stake by 20% in Q4 2025, selling an estimated $324K and leaving 52,880 shares worth $1.32M. The position accounts for 0.08% of the portfolio, ranked #142.
Janney Capital Management first reported a position in PFE in Q2 2013 and has held it in 49 quarters since. The position peaked at $27.3M in Q3 2018. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Janney Capital Management held 52,880 shares of Pfizer worth $1.32M as of Q4 2025.
- Janney Capital Management sold 12,843 Pfizer shares in Q4 2025, an estimated $324K.
- Pfizer made up 0.08% of Janney Capital Management's portfolio in Q4 2025, its #142 holding.
- Janney Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 49 quarters since.
- Janney Capital Management's Pfizer position peaked at $27.3M in Q3 2018.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Janney Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.